Vice President, Corporate Development
Vik joined Tessera in 2020 as the Head of Corporate Development. Vik drives corporate strategy, business development, and investor relations for Tessera.
Vik was previously at McKinsey & Company, where he was an Associate Partner in the healthcare practice. At McKinsey, Vik worked with large biopharma and early-stage biotech companies on strategy, M&A, and R&D topics. He led diligence efforts for over $15B in completed deals and advised on clinical strategy for more than 20 programs. Vik also co-led McKinsey’s Center for Asset Optimization, which focuses on clinical-stage asset development strategy. Vik holds a Ph.D. in Genetics and Development from Columbia University, where he studied transcriptional regulation of developmentally important genes at the molecular level. He has a B.S. in biochemistry from Brandeis University, where he was awarded highest honors for his research on DNA damage repair pathways.